AlphaLiquid®

The Liquid Biopsy of IMB Dx,  AlphaLiquid, provides targeted gene results that can help direct therapy selection and clinical trial options for advanced-stage cancer patients using an invasive way.


By analyzing SNV, CNV, InDel, SV of ctDNA with our comprehensive genomic profiling approach and providing clinical reports, The Liquid Biopsy of IMB Dx empowers clinicians to make more informed clinical decisions even when tissue is not ideal.
(Research Use Only)

Process of AlphaLiquid®

 AlphaLiquid®


 The Liquid Biopsy of IMB Dx, AlphaLiquid , provides targeted gene results that can help direct therapy 

selection and clinical trial options for advanced-stage cancer patients using an invasive way. 


By analyzing SNV, CNV, InDel, SV of ctDNA with our comprehensive genomic profiling approach 

and providing clinical reports, The Liquid Biopsy of IMB Dx empowers clinicians to 

make more informed clinical decisions even when tissue is not ideal.
(Research Use Only)

Results

Survival rates can be higher when cancer is diagnosed at earlier stages. It is known that cancer be directly detectable with circulating tumor DNA shed by tumors into the blood.


IMB Dx aims to develop the automated blood test to prevent human error.

Results


Survival rates can be higher when cancer is diagnosed at earlier stages. It is known that cancer be 

directly detectable with circulating tumor DNA shed by tumors into the blood. 

IMB Dx aims to develop the automated blood test to prevent human error.

Reference Genome

Sample

SNV

(Single Nucleotide Variation)

SV

(Structural Variation)

SNV

(Single Nucleotide Variation)

SV

(Structural Variation)

InDel

(Insertion & Deletion)

CNV

(Copy Number Variation)

InDel

(Insertion & Deletion)

CNV

(Copy Number Variation)

IMB Dx

Address : 20F, Bldg A, BYC Highcity, 131, Gasan digital 1-ro, Geumcheon-gu, Seoul, 08506, Korea

Tel : +82-26951-2906  ㅣ  Fax : +82-26947-3705  ㅣ  E-mail : info@imbdx.com

Copyright ⓒ IMB Dx, lnc.  All rights reserved.